...
首页> 外文期刊>Journal of cardiology >Thallium scintigraphy for the prognosis of idiopathic dilated cardiomyopathy.
【24h】

Thallium scintigraphy for the prognosis of idiopathic dilated cardiomyopathy.

机译:hall闪烁显像用于特发性扩张型心肌病的预后。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: This study evaluated the significance of perfusion defects demonstrated by thallium-201 and age in the prognosis of patients with idiopathic dilated cardiomyopathy. METHODS: Seventy-four dilated cardiomyopathy patients underwent thallium scintigraphy as well as clinical and hemodynamic examination. RESULTS: Abnormal perfusion defects were present in 23 of 38 patients aged < 60 years (61%) and in 26 of 36 elderly patients aged > or = 60 years (72%; NS). Univariate analysis showed that such perfusion defects were a significant predictor of cardiac death only in patients aged < 60 years (p = 0.015). Stepwise discriminant analysis also revealed that perfusion defects were a significant predictor in patients aged < 60 years (Wilks' lambda 0.499, chi-square test 20.2, p = 0.003). Perfusion defects were not more important than the history of syncope or stroke in elderly dilated cardiomyopathy patients. Twenty-one patients died of disease-related causes during 58 +/- 43 months. The five-year survival rate was better in patients aged < 60 years without than in those with perfusion defects (100% vs 58.4%, respectively), but not affected in patients aged > or = 60 years (66.7% vs 62.2%). CONCLUSIONS: Thallium scintigraphy is valuable for the prognosis of patients with dilated cardiomyopathy aged < 60 years who are usually candidates for heart transplantation. Absence of thallium perfusion defects may indicate good long-term prognosis.
机译:目的:本研究评估了-201表现出的灌注缺陷和年龄在特发性扩张型心肌病患者预后中的意义。方法:对74例扩张型心肌病患者进行th闪烁显像以及临床和血液动力学检查。结果:38岁<60岁的患者中有23例存在灌注异常(61%),≥60岁的36例老年患者中有26例存在72%(NS)。单因素分析表明,这种灌注缺陷仅在<60岁的患者中才是心源性死亡的重要预测指标(p = 0.015)。逐步判别分析还显示,灌注缺陷是<60岁患者的重要预测指标(Wilksλ0.499,卡方检验20.2,p = 0.003)。在老年扩张型心肌病患者中,灌注缺陷并不比晕厥或中风病史重要。在58 +/- 43个月内,有21名患者死于与疾病相关的原因。 <60岁且无灌注的患者的5年生存率要好于有灌注缺陷的患者(分别为100%对58.4%),但对于≥60岁的患者则不受影响(66.7%对62.2%)。结论:hall闪烁显像对于年龄<60岁的扩张型心肌病患者的预后很有价值,这些患者通常是心脏移植的候选人。 th灌注缺损可能预示良好的长期预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号